New cancer drug injected directly into tumors shows early promise
Disease control
Completed
This early-stage study tested the safety and initial effectiveness of an experimental immunotherapy called JCXH-211. The drug was injected directly into tumors of 19 patients with advanced solid cancers who had no other treatment options. The main goal was to see if the treatment…
Phase: PHASE1 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC